a company, which engages in development and commercialization of serlopitant products
Industry Biotechnology
A.I.dvisor tells us that VYNE and GLTO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VYNE and GLTO's prices will move in lockstep.
Ticker / NAME | Correlation To VYNE | 1D Price Change % | ||
---|---|---|---|---|
VYNE | 100% | -2.41% | ||
GLTO - VYNE | 30% Poorly correlated | +0.44% | ||
AURA - VYNE | 30% Poorly correlated | -3.48% | ||
OBIO - VYNE | 28% Poorly correlated | +2.31% | ||
ELVN - VYNE | 27% Poorly correlated | -3.41% | ||
SANA - VYNE | 27% Poorly correlated | -2.63% | ||
More |
Ticker / NAME | Correlation To VYNE | 1D Price Change % |
---|---|---|
VYNE | 100% | -2.41% |
pharmaceuticals theme (159 stocks) | 14% Poorly correlated | -1.90% |
generic products theme (73 stocks) | 13% Poorly correlated | -0.43% |